Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.80%-3.07M | -89.19%-1.79M | -483.57%-3.55M | -16.84%-6.47M | -22.62%-3.4M | -2.14%-1.52M | -21.71%-948.57K | -20.77%-608.89K | 37.48%-5.54M | 17.19%-2.77M |
| Net income from continuing operations | -13.84%-2.77M | -43.50%-3.76M | -174.67%-3.78M | 5.59%-8.85M | 18.11%-2.42M | -40.13%-2.43M | -2.29%-2.62M | 35.10%-1.38M | 22.95%-9.37M | 28.17%-2.95M |
| Operating gains losses | --0 | --0 | -163.33%-18.51K | --824.2K | --794.97K | --0 | --0 | --29.23K | ---- | ---- |
| Depreciation and amortization | -37.28%60.32K | -69.09%32.85K | -12.74%104.04K | -33.19%396.32K | 121.00%74.65K | -68.80%96.17K | -64.58%106.26K | -64.98%119.23K | -47.23%593.17K | -234.00%-355.51K |
| Asset impairment expenditure | 149.49%34.49K | -14.45%166.5K | -260.69%-29.81K | 1.49%349.3K | -40.20%205.81K | ---69.68K | --194.62K | --18.55K | 774.41%344.16K | 13,220.78%344.16K |
| Remuneration paid in stock | 64.88%279.14K | 130.77%414.28K | 1,160.02%595.65K | -35.99%384.7K | -110.73%-11.39K | 109.26%169.3K | -7.17%179.52K | -78.57%47.27K | -69.75%601K | -74.73%106.13K |
| Other non cashItems | -25.31%376.23K | -3.08%366.66K | -31.50%277.64K | 65.36%1.65M | -61.33%362.94K | 2,362.61%503.75K | 751.91%378.32K | 7,608.41%405.3K | 1,741.93%998.01K | 2,062.05%938.55K |
| Change In working capital | -582.62%-1.05M | 21.14%982.88K | -566.86%-697.64K | -194.85%-1.23M | -182.15%-2.41M | 239.15%218.3K | -34.72%811.33K | -85.95%149.43K | 1,209.00%1.3M | -2,501.61%-853.44K |
| -Change in receivables | -192.27%-455.09K | 167.01%429.88K | -771.09%-605.09K | -2,575.87%-1.41M | -301.77%-1.19M | 212.16%493.22K | -191.58%-641.49K | -154.53%-69.46K | 162.66%56.81K | 592.21%589.17K |
| -Change in inventory | -90.68%43.22K | -235.94%-916.45K | 417.92%551.31K | 108.81%105.69K | -253.76%-858.58K | 210.11%463.53K | 226.24%674.16K | -6,817.07%-173.41K | -128.63%-1.2M | 26.91%-242.7K |
| -Change in payables and accrued expense | -512.38%-541.66K | 3,166.39%1.39M | -29.67%-852.81K | -79.79%456.55K | 196.68%1.16M | -116.88%-88.45K | -97.86%42.69K | -170.09%-657.69K | 216.13%2.26M | -346.24%-1.2M |
| -Change in other working capital | 84.61%-100.01K | -89.81%75K | -80.10%208.95K | -313.71%-384.68K | ---1.52M | ---650K | --735.97K | --1.05M | --180K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -102.80%-3.07M | -89.19%-1.79M | -483.57%-3.55M | -16.84%-6.47M | -22.62%-3.4M | -2.14%-1.52M | -21.71%-948.57K | -20.77%-608.89K | 37.48%-5.54M | 17.19%-2.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -265.59%-109.9K | 98.99%-938 | -7,687.15%-151.46K | 45.17%-121.22K | 216.54%3.99K | -123.51%-30.06K | 70.28%-93.2K | 93.92%-1.95K | 76.11%-221.1K | 94.60%-3.42K |
| Net PPE purchase and sale | -588.05%-109.9K | 98.99%-938 | -7,687.15%-151.46K | 14.34%-94.11K | -34.33%17.01K | 43.07%-15.97K | -17.92%-93.2K | 93.22%-1.95K | 85.73%-109.86K | 137.28%25.91K |
| Net intangibles purchas and sale | ---- | ---- | ---- | 75.63%-27.11K | 55.60%-13.02K | -109.03%-14.09K | ---- | ---- | 28.56%-111.23K | -576.49%-29.33K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -265.59%-109.9K | 98.99%-938 | -7,687.15%-151.46K | 45.17%-121.22K | 216.54%3.99K | -123.51%-30.06K | 70.28%-93.2K | 93.92%-1.95K | 76.11%-221.1K | 94.60%-3.42K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 93.75%3.47M | -185.36%-585.95K | 406.52%5.05M | 53.50%7.78M | 59.28%4.31M | 66.39%1.79M | -47.23%686.42K | 8,161.06%996.27K | -45.50%5.07M | -16.95%2.7M |
| Net issuance payments of debt | -77.34%409.23K | -603.53%-491.57K | 63.51%-182.6K | -40.65%705.37K | -151.33%-697.93K | 2,909.97%1.81M | 210.37%97.63K | -2,610.86%-500.37K | 960.19%1.19M | 2,103.15%1.36M |
| Net common stock issuance | 21,222.17%3.06M | -119.56%-98.08K | 110.94%3.16M | 91.16%6.99M | 347.02%5.01M | -101.27%-14.5K | -63.91%501.43K | 24,439.06%1.5M | -61.03%3.66M | -66.32%1.12M |
| Proceeds from stock option exercised by employees | --0 | -95.76%3.7K | --2.07M | -61.16%87.37K | --0 | --0 | --87.37K | --0 | 283.95%224.92K | --224.92K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 93.75%3.47M | -185.36%-585.95K | 406.52%5.05M | 53.50%7.78M | 59.28%4.31M | 66.39%1.79M | -47.23%686.42K | 8,161.06%996.27K | -45.50%5.07M | -16.95%2.7M |
| Net cash flow | ||||||||||
| Beginning cash position | 102.71%355.69K | 568.74%2.66M | 119,653.79%1.15M | -99.86%963 | 2,766.80%390.52K | -34.02%175.47K | 269.37%397.32K | -99.86%963 | -49.50%677.47K | -96.41%13.62K |
| Current changes in cash | 17.00%287.99K | -570.17%-2.38M | 248.05%1.34M | 273.01%1.19M | 1,429.04%915.06K | 188.20%246.14K | -270.93%-355.35K | 170.26%385.43K | -43.52%-688.57K | 54.56%-68.85K |
| Effect of exchange rate changes | 91.11%-2.77K | -39.96%80.15K | 1,385.45%162.3K | -423.45%-39.01K | -371.12%-152.35K | -216.25%-31.09K | 369.66%133.5K | 151.13%10.93K | 106.54%12.06K | -87.50%56.19K |
| End cash Position | 64.12%640.91K | 102.71%355.69K | 568.74%2.66M | 119,653.79%1.15M | 119,653.79%1.15M | 2,766.80%390.52K | -34.02%175.47K | 269.37%397.32K | -99.86%963 | -99.86%963 |
| Free cash from | -105.97%-3.18M | -72.35%-1.8M | -506.51%-3.7M | -14.46%-6.59M | -22.33%-3.39M | -13.99%-1.55M | 4.97%-1.04M | -14.63%-610.84K | 41.13%-5.76M | 18.63%-2.77M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.